| 2023年年报 | 2023年中报 | 2022年年报 | 2022年中报 | |
|---|---|---|---|---|
| 营业收入(元) | ||||
| 药品收入(元) | 774,117,233.84 | 199,121,892.85 | - | 190,517,918.17 |
| 医疗收入(元) | 2,806,334,263.40 | 1,400,933,403.02 | 2,642,340,373.30 | 1,319,398,477.70 |
| 制药收入(元) | - | - | 483,455,052.29 | - |
| 其他产品(元) | 10,030,562.83 | 6,668,069.11 | 26,939,455.04 | 11,550,123.25 |
| 营业成本(元) | ||||
| 药品收入(元) | 431,178,072.39 | 58,365,535.34 | - | 38,730,944.37 |
| 医疗收入(元) | 2,066,534,728.56 | 1,018,570,181.12 | 2,020,732,068.07 | 1,023,847,264.46 |
| 制药收入(元) | - | - | 98,640,491.98 | - |
| 其他产品(元) | 12,842,767.24 | 2,168,987.75 | 40,723,036.16 | 18,729,275.41 |
| 毛利(元) | ||||
| 药品收入(元) | 342,939,161.45 | 140,756,357.51 | - | 151,786,973.80 |
| 医疗收入(元) | 739,799,534.84 | 382,363,221.90 | 621,608,305.23 | 295,551,213.24 |
| 制药收入(元) | - | - | 384,814,560.31 | - |
| 其他产品(元) | -2,812,204.41 | 4,499,081.36 | -13,783,581.12 | -7,179,152.16 |
| 毛利率(%) | ||||
| 药品收入(%) | 44.30 | 70.69 | - | 79.67 |
| 医疗收入(%) | 26.36 | 27.29 | 23.52 | 22.40 |
| 制药收入(%) | - | - | 79.60 | - |
| 其他产品(%) | -28.04 | 67.47 | -51.17 | -62.16 |
| 收入构成(%) | ||||
| 药品收入(%) | 21.56 | 12.39 | - | 12.52 |
| 医疗收入(%) | 78.16 | 87.19 | 83.81 | 86.72 |
| 制药收入(%) | - | - | 15.33 | - |
| 其他产品(%) | 0.28 | 0.42 | 0.85 | 0.76 |
| 毛利构成(%) | ||||
| 药品收入(%) | 31.76 | 26.68 | - | 34.48 |
| 医疗收入(%) | 68.50 | 72.47 | 62.62 | 67.15 |
| 制药收入(%) | - | - | 38.77 | - |
| 其他产品(%) | -0.26 | 0.85 | -1.39 | -1.63 |